Research graph
References from The helminth-derived effector protein HpBARI trimerises to selectively target membrane bound ST2 receptor. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41577-026-01345-8
10.1038/s41577-026-01345-8 · External reference
10.1038/s41423-025-01261-2
10.1038/s41423-025-01261-2 · External reference
10.1016/j.immuni.2005.09.015
10.1016/j.immuni.2005.09.015 · External reference
ILC2 require cell-intrinsic ST2 signals to promote type 2 immune responses
10.3389/fimmu.2023.1130933 · 2023 · External reference
10.1016/j.immuni.2017.08.004
10.1016/j.immuni.2017.08.004 · External reference
10.1016/j.str.2009.08.009
10.1016/j.str.2009.08.009 · External reference
10.1016/j.jaci.2021.03.044
10.1016/j.jaci.2021.03.044 · External reference
Astegolimab, an anti-ST2, in chronic obstructive pulmonary disease (COPD-ST2OP): a phase 2a, placebo-controlled trial
10.1016/s2213-2600(21)00556-7 · 2022 · External reference
10.1038/s41385-019-0138-4
10.1038/s41385-019-0138-4 · External reference
10.1172/jci.insight.203283
10.1172/jci.insight.203283 · External reference
10.1074/jbc.m704916200
10.1074/jbc.m704916200 · External reference
Constitutively high levels of endogenous soluble ST2 inhibit food allergic responses in mice
10.1073/pnas.2506485123 · 2026 · External reference
10.1073/pnas.1206587110
10.1073/pnas.1206587110 · External reference
10.1016/j.celrep.2017.05.001
10.1016/j.celrep.2017.05.001 · External reference
10.1002/eji.201142161
10.1002/eji.201142161 · External reference
10.1038/mi.2013.123
10.1038/mi.2013.123 · External reference
HpARI Protein Secreted by a Helminth Parasite Suppresses Interleukin-33
10.1016/j.immuni.2017.09.015 · 2017 · External reference
10.7554/elife.54017
10.7554/elife.54017 · External reference
10.1038/s41467-024-49550-0
10.1038/s41467-024-49550-0 · External reference
10.7554/elife.99000.3
10.7554/elife.99000.3 · External reference
IL-33-binding HpARI family homologues with divergent effects in suppressing or enhancing type 2 immune responses
10.1128/iai.00395-23 · 2024 · External reference
10.64898/2026.09.02.748793
10.64898/2026.09.02.748793 · External reference
The interleukin-33 receptor (ST2) is a novel therapeutic target to attenuate the progression of hemophilic arthropathy
10.1182/blood.2024027578 · 2025 · External reference
10.1101/2024.11.27.625579
10.1101/2024.11.27.625579 · External reference
IL-33/ST2 axis in diverse diseases: regulatory mechanisms and therapeutic potential
10.3389/fimmu.2025.1533335 · 2025 · External reference
IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial
10.1016/j.jacig.2022.07.002 · 2022 · External reference
10.1183/23120541.01202-2025
10.1183/23120541.01202-2025 · External reference
10.1038/386194a0
10.1038/386194a0 · External reference
10.1038/ni.1925
10.1038/ni.1925 · External reference
10.4049/jimmunol.1400538
10.4049/jimmunol.1400538 · External reference
10.1002/1529-0131(199806)41:6<1083::aid-art15>3.0.co;2-9
10.1002/1529-0131(199806)41:6<1083::aid-art15>3.0.co;2-9 · External reference
10.1136/gut.43.2.203
10.1136/gut.43.2.203 · External reference
10.1164/ajrccm.164.2.2008120
10.1164/ajrccm.164.2.2008120 · External reference
10.1016/j.jsb.2021.107702
10.1016/j.jsb.2021.107702 · External reference
DeepEMhancer: a deep learning solution for cryo-EM volume post-processing
10.1038/s42003-021-02399-1 · 2021 · External reference
10.1002/pro.3943
10.1002/pro.3943 · External reference
10.1107/s0907444904019158
10.1107/s0907444904019158 · External reference
10.1107/s2059798319011471/https://goldbook.iupac.org/e02002.html
10.1107/s2059798319011471/https://goldbook.iupac.org/e02002.html · External reference
10.1038/s41556-024-01377-z
10.1038/s41556-024-01377-z · External reference
